secwatch.observer — SEC 8-K summary
======================================

Issuer:     MeiraGTx Holdings plc (MGTX)
CIK:        0001735438
Form:       8-K
Filed at:   2026-09-23T12:12:35+00:00
Accession:  0001104659-26-109824
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MeiraGTx appoints Alan M. Sebulsky to Board as Class I director effective Sept 23, 2026
--------------------------------------------------------------------------------

- Sebulsky, Managing Member of Apothecary Capital, joins as Class I director with term expiring at 2028 annual meeting.
- Appointed to Science and Technology Committee; eligible for Non-Employee Director Compensation.
- Ex-Partner at Adage Capital for 14 years, managing a biopharma portfolio with over $2B in assets.
- Current board member of Parabilis Medicines; former director of Jazz Pharmaceuticals and Arrow International.
- CEO Alexandria Forbes cites his 25-year relationship and biopharma investing experience as valuable as company transitions to commercial.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1735438/000110465926109824/0001104659-26-109824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1735438/000110465926109824/mgtx-20260922x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-109824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer